Pharmaceuticals

Industry Trends Show Fentanyl Market Set to Expand at 5.5% CAGR Until 2029

September 1, 2025 by Marketing Posting

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_

_x000D_

#What Does the Forecast Indicate for the Fentanyl Market From 2025 to 2029?#_x000D_

In recent years, the metronidazole market has experienced significant growth, with projections showing an increase from $0.58 billion in 2024 to $0.61 billion in 2025, corresponding to a compound annual growth rate (CAGR) of 5.2%. This historic growth is largely due to favorable health insurance reimbursement policies, increased funding for research into infectious diseases, a rise in cases of oral and dental infections, the escalating prevalence of inflammatory bowel diseases, and an expanding aging population._x000D_

_x000D_

In the coming years, the metronidazole market is projected to witness a robust growth, expanding to “$0.76 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. This growth is primarily due to factors such as increasing rates of bacterial and protozoal infections, surges in gastrointestinal disorders, heightened demand for cost-effective, generic antibiotics, improved healthcare structure, and governmental efforts towards controlling infectious disease. The forecast period will also see dominant trends such as advancement in pharmaceutical manufacturing processes, strategic partnerships among pharmaceutical companies, expansion of pharmaceutical contract manufacturing sectors, use of nanotechnology in drug delivery systems, and development in innovative pH-responsive metronidazole formulations._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=21222&type=smp_x000D_

_x000D_

#What Elements Are Contributing To Growth In The Fentanyl Market?#_x000D_

The escalating occurrence of chronic ailments is anticipated to fuel the expansion of the fentanyl market in the future. Chronic illness refers to a health issue that lingers for an extended length of time, usually at least three months and frequently lasts throughout an individual’s lifetime. Fentanyl is primarily utilized in chronic illnesses to control severe, constant pain that other drugs or treatments fail to effectively manage. For example, according to the Heart Disease Facts issued by the US-based public health agency, the Centers for Disease Control and Prevention (CDC), in the United States in October 2024, coronary heart disease (CHD) caused 371,506 deaths in 2022, adding up to the total 702,880 heart disease deaths, which represented approximately one in every five deaths. Hence, the growing prevalence of chronic diseases is propelling the fentanyl market’s expansion._x000D_

_x000D_

The metronidazole market covered in this report is segmented – _x000D_

_x000D_

1) By Formulation Type: Tablets, Capsules, Intravenous (IV) Solutions, Topical Creams Or Ointments, Other Formulation Types_x000D_

2) By Application: Bacterial Infections, Parasitic Infections, Gynecological Infections, Surgical Prophylaxis, Other Applications_x000D_

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels_x000D_

4) By End-User: Hospitals, Clinics, Homecare, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Tablets: Immediate Release Tablets, Extended Release Tablets _x000D_

2) By Capsules: Immediate Release Capsules, Extended Release Capsules _x000D_

3) By Intravenous (IV) Solutions: Single-dose IV Solutions, Multi-dose IV Solutions _x000D_

4) By Topical Creams Or Ointments: Topical Creams, Topical Ointments _x000D_

5) By Other Formulation Types: Oral Suspension, Vaginal Gels Or Suppositories_x000D_

_x000D_

#Which Emerging Trends And Strategic Shifts Are Shaping The Fentanyl Market?#_x000D_

Prominent organizations in the metronidazole market are concentrating on the creation of cutting-edge solutions, including ready-to-use oral liquids, intended to improve patient adherence, particularly for individuals who struggle with tablet consumption or need simpler administration methods for infection treatment. Ready-to-use oral liquids are pre-mixed liquid drugs that do not necessitate further preparation or blending before usage, offering ease to patients. For example, in November 2023, Kesin Pharma Corporation, an American specialty pharmaceutical firm, reported that the FDA had green-lighted LIKMEZ (metronidazole) oral suspension, 500 mg/5 mL. This freshly formulated version of a regularly used antibiotic is aimed at augmenting patient compliance. It has been sanctioned for the treatment of trichomoniasis and anaerobic bacterial infections in adults, and amebiasis in both adults and children. LIKMEZ is available as a strawberry peppermint-flavored suspension in a 200 mL bottle and lasts 24 months without needed refrigeration._x000D_

_x000D_

#Who Are The Key Contributors To Growth In The Fentanyl Market?#_x000D_

Major companies operating in the metronidazole market are Pfizer Inc., Merck & Co. Inc., Abbott Laboratories, Fresenius Kabi AG, Baxter International Inc., Sandoz Group AG, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Cipla Limited, Dr. Reddy’s Laboratories Ltd., Lupin Pharmaceuticals Inc., Zydus Lifesciences, YiChang HEC ChangJiang Pharmaceutical Co. Ltd., Aarti Drugs Ltd., Unichem Laboratories, Cosette Pharmaceuticals Inc., Saptalis Pharmaceuticals LLC, Huanggang Saikang Pharmaceutical Co. Ltd., Kesin Pharma, Hubei Hongyuan Pharmaceutical Technology Co. Ltd., Huanggang Yinhe Aarti Pharmaceutical Co. Ltd., Higgs Healthcare _x000D_

_x000D_

https://www.thebusinessresearchcompany.com/report/metronidazole-global-market-report_x000D_

_x000D_

#Which Region Is Projected To Lead The Fentanyl Market By 2025?#_x000D_

Asia-Pacific was the largest region in the metronidazole market in 2024. The regions covered in the metronidazole market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=21222&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_